迪堡金融設備 DBD 深 滬
已收盤 02-06 16:00:00 美东时间
71.81
+2.460
+3.55%
華盛通- 最 高72.25
- 今 開70.00
- 成交量 34.32万股
- 最 低 70.00
- 昨 收 69.35
- 總市值 25.76亿
- 52周最高 72.53
- 市盈率 靜 --
- 換手率 0.96%
- 52周最低 34.875
- 委 比 33.33%
- 總股本 3586.72万
- 歷史最高 72.53
- 量 比 1.17
- 振 幅 3.24%
- 歷史最低 16.50
- 每 手 1
- 風險率 9.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多New Study Reveals How Self-Service is Reshaping Retail in Australia
Key findings include self-service as preferred checkout option for consumers, valuing speed, simplicity and control, but also point out what should be improved NORTH CANTON, Ohio, Jan. 29, 2...
01-29 21:04
Moody's Ratings Upgrades Diebold Nixdorf's Credit Rating to B1
NORTH CANTON, Ohio, Dec. 17, 2025 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, today announced that Moody's Ratings (Moody's) upg...
2025-12-17 21:07
Diebold Nixdorf Boosts Operational Continuity of Autogrill Restaurants in Italy
Extended managed services for the entire restaurant IT ecosystem ensure the highest touchpoint availability and enhanced traveler experiences NORTH CANTON, Ohio, Dec. 16, 2025 /PRNewswire/ -...
2025-12-16 21:04
Diebold Nixdorf Unveils DN Series® 300 and 350: Transforming Self-Service Banking
New cash dispensers, powered by the new DM7V dispensing module, combine the industry's highest capacity with the smallest footprint, reducing operational cost. NORTH CANTON, Ohio, Dec. 2, 20...
2025-12-02 21:03
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
2025-11-19 11:01
Wedbush Reiterates Outperform on Diebold Nixdorf, Maintains $80 Price Target
Wedbush analyst Antoine Legault reiterates Diebold Nixdorf (NYSE:DBD) with a Outperform and maintains $80 price target.
2025-11-18 21:53
